Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bunce

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Leukemia & Lymphoma|December 29, 1999
Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemiaM Bentley, K Taylor, A Grigg, et al.
Australian and New Zealand Journal of Medicine|October 1, 1992
All-trans retinoic acid in the treatment of acute promyelocytic leukaemiaK L White, J S Wiley, T Frost, et al.
Australian and New Zealand Journal of Medicine|April 14, 1999
Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemiaA K Mills, K M Taylor, S J Wright, et al.
Thrombosis Research|September 15, 1983
An immunoassay for human D dimer using monoclonal antibodiesD B Rylatt, A S Blake, L E Cottis, et al.
Leukemia Research|March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorJ Morton, P Mollee, K Taylor, et al.
British Journal of Haematology|October 1, 1996
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study GroupJ Morton, K Taylor, I Bunce, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Leukemia & Lymphoma|December 29, 1999
Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemiaM Bentley, K Taylor, A Grigg, et al.
Australian and New Zealand Journal of Medicine|October 1, 1992
All-trans retinoic acid in the treatment of acute promyelocytic leukaemiaK L White, J S Wiley, T Frost, et al.
Australian and New Zealand Journal of Medicine|April 14, 1999
Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemiaA K Mills, K M Taylor, S J Wright, et al.
Thrombosis Research|September 15, 1983
An immunoassay for human D dimer using monoclonal antibodiesD B Rylatt, A S Blake, L E Cottis, et al.
Leukemia Research|March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorJ Morton, P Mollee, K Taylor, et al.
British Journal of Haematology|October 1, 1996
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study GroupJ Morton, K Taylor, I Bunce, et al.
Pageof 2